BREAKING NEWS The IWMF is excited to share that the U.S. Food and Drug Administration (FDA) has approved the use of Zanubrutinib for the treatment of WM. From IWMF Board Chair, Peter DeNardis: “The approval of Brukinsa in Waldenström’s macroglobulinemia, which is the...
To achieve its strategic visions, the IWMF recognizes it is vital to provide funding to support the career development of next-generation researchers for WM. The IWMF is therefore proud to announce the establishment of the Robert A. Kyle Career Development Awards for...
Founded in 2001, Charity Navigator is the nation’s largest and most-utilized evaluator of charities. To help donors decide which non-profits are worthy of support, their team of professional analysts examines tens of thousands of non-profit financial documents....
WM Patient-Entered Data Published in American Journal of Hematology – More Data Is Needed and You Can Help! Congratulations to all who entered their data into the WhiMSICAL Registry. Your efforts have directly added to the field of WM research. Newly published...
REGISTRATION OPEN AT OUR NEW EVENTS SITE! IWMF Global Educational Webinar July 9, 2021 at 1:30PM U.S. ET The IWMF is excited to share that we have a new platform host for our Virtual Events, which includes Global Educational Webinars and Ed Forum Month in...
As many of you in the US are now aware, the CDC issued new recommendations for fully vaccinated people in non-healthcare settings (see: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html). The guidelines state the following: Fully...
To the IWMF Community, We want to let you know that after very careful consideration and with input from our WM medical experts, we have made the decision that our 2021 Ed Forum will be a completely virtual event. We are disappointed that we will not be together in...
IWMF Global Educational Webinar Peripheral Neuropathy: No Easy Feat May 4, 2021 1:30PM U.S. ET REGISTER HERE REGISTER...
